Two-year outcomes of primary prophylactic use of defibrillators with ischemic and non-ischemic cardiomyopathy: propensity score-matched analysis from NIPPON STORM Study

Back

ESC Professional Premium Access

Two-year outcomes of primary prophylactic use of defibrillators with ischemic and non-ischemic cardiomyopathy: propensity score-matched analysis from NIPPON STORM Study

Session: Recent advances in implantable cardioverter defibrillator therapy

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Associate Professor Y. Kondo (Chiba, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Associate Professor Yusuke Kondo

Chiba University Graduate School of Medicine, Chiba (Japan)

1 follower

5 more presentations in this session

Chronic safety and performance of the extravascular ICD: results from the global EV ICD Pivotal study

Speaker: Professor L. Boersma (Nieuwegein, NL)

Subcutaneous versus transvenous ICDs: a population-level comparison of incidence, patient characteristics, and complications of S-ICDs, ICDs, and CRT-Ds in a nationwide Dutch cohort (2018-2020)

Speaker: Assistant Professor M. Samuel (Groningen, NL)

Local anesthesia during S-ICD implantation gives similar post procedural pain perception as sedation

Speaker: Ms J. De Veld (Amsterdam, NL)

Real world battery longevity of the subcutaneous implantable cardioverter-defibrillator (S-ICD)

Speaker: Miss W. van der Stuijt (Amsterdam, NL)

Marked differences in ICD therapy frequencies between phenotypes

Speaker: Doctor C. Zheng (Copenhagen, DK)

Access the full session

Recent advances in implantable cardioverter defibrillator therapy

Speakers: Associate Professor Y. Kondo, Professor L. Boersma, Assistant Professor M. Samuel, Ms J. De Veld, Miss W. van der Stuijt...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources